Intercept Prices 1.2M Shares, Proceeds To Be ~$338.4M By: Benzinga via Benzinga March 31, 2015 at 09:14 AM EDT Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT) (Intercept), a clinical stage biopharmaceutical company focused on the development and ... Read More >> Related Stocks: Intercept Pharmaceuticals Renaissance International IPO ETF